tirzepatide normal bmi reddit Gastrointestinal tolerability and weight reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 Oral semaglutide 25 mg, not
Description
GLP-1 receptor agonists have transformed weight loss treatment, with clinical trials showing 15-22% body weight reduction in patients using semaglutide or tirzepatide
It is an MHRA-approved treatment for conditions such as depression and panic disorder

Despite sharing the same active molecule, the journey of semaglutide into two distinct medications with different purposes is a testament to targeted drug development

Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacy
